Pharmacy technicians’ training scrutinised
A new report released by the General Pharmaceutical Council (GPhC) sheds light on the perceptions of pharmacy technician education standards
The document covers the scope of the current initial education and training (IET) standards for pharmacy technicians and the extent to which the employers of pharmacy technicians and other stakeholders think the current IET standards are fit for purpose.
All current IET standards were considered to be essential, but some parts of the current curricula were not considered to be current or contemporary and could be revised
The length of IET and the academic level were thought to be appropriate, although may need to be changed if the role evolves further
Funding of training has an impact on the standards of IET and there is a disparity in funding opportunities between hospital and community.
— GPhC (@TheGPhC) December 4, 2015
Two new online courses launched
The Centre for Pharmacy Postgraduate Education (CPPE) has launched two new e-learning programmes as an expansion of their consultation skills portfolio, the PSNC have reported.
Consulting with children and young people has been developed to encourage pharmacy professionals to place children at the centre of their own care, describing the skills and knowledge needed to engage with them successfully.
Consulting with people with mental health problems covers what is different about consulting with people with mental health problems and how to prepare and approach these consultations so that people get the most benefit from them.
Superbug resistant to last-resort antibiotics in Europe
Scientists in Denmark have identified the presence of E.coli that is resistant to all antibiotics in current usage.
Katherine Murphy, chief executive of the Patients Association said: “At a time when antibiotic resistant E. coli infections have risen by 15%, the inadequacy of last resort antibiotics is fast approaching.
“The Patients Association is calling on the Government to take action now, to tighten up infection control guidelines and to address the root causes of antibiotic resistance.”
— Poul Birch Eriksen (@pobier) December 4, 2015
UK pays less for new cancer dugs
The UK is paying less for new cancer drugs than a number of other high-income countries, the BBC has reported.
According to a report in The Lancet Oncology the UK, Greece, Spain and Portugal pay the least, on average, for the drugs they use while Germany, Sweden and Switzerland pay the most.
The authors said more transparency was needed because some countries risked overpaying for drugs.
The pharmaceutical industry said the UK was getting a fair deal on medicines.
Prices of cancer drugs have risen steeply in recent years, placing major stress on many healthcare systems, including the NHS.
Cancer drug prices vary widely across Europe, study finds https://t.co/UbQYeZMUdl
— Kyle D'Silva (@PharmaAnalysis) December 4, 2015